InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Olwill Shane, Directeur du Développement. Insider active across 1 company, notably Pieris Pharmaceuticals, INC.. Cumulatively, 1 filings have been recorded. Activity tracked since 30 August 2021. The latest transaction was filed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Olwill Shane is the Chief Development Officer at PIERIS PHARMACEUTICALS, INC. He is responsible for product development strategy and innovation. Shane leverages his expertise to identify new opportunities and strengthen the company's market position.